Martin Alberer1, Svea Malinowski2, Linda Sanftenberg2, Jörg Schelling2. 1. Division of Infectious Diseases and Tropical Medicine, Medical Center of the Ludwig-Maximilians-University (LMU), Munich, Germany. martin.alberer@lrz.uni-muenchen.de. 2. Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.
Abstract
PURPOSE: In 2016, the number of refugees worldwide reached 65.6 million. So far, only limited data are available on the health status of refugees and asylum seekers (RAs). Especially, notifiable infectious diseases (NIDs) carry the risk of outbreaks in communal accommodations hosting RAs. METHODS: We conducted a monocentric retrolective cross-sectional study including 15,137 RAs treated in a special health care unit for RAs located in the major reception center in Munich from November 2014 to October 2016. Altogether 811 RAs with NIDs according to sections 6 and 7 of the German Infection Protection Act or with other infections relevant in the setting of a communal accommodation (RIDs) could be identified. RESULTS: The gender and age distribution was generally comparable to that of refugees in Germany. However, patients from East Africa and Nigeria were significantly overrepresented. NIDs/RIDs were dominated by cases of tuberculosis, hepatitis B, and vaccine-preventable and parasitic diseases. Significant risk factors included country of origin (COI) and age for hepatitis B, age for hepatitis C, gender and age for HIV, and COI, gender and age for tuberculosis and ectoparasitosis. Calculated prevalences of hepatitis B, hepatitis C, and HIV were mostly below those of the COI. Incidences of tuberculosis were mostly strongly elevated. CONCLUSIONS: COI, gender, and age have an impact on the occurrence of NIDs/RIDs. Early vaccinations and improved hygiene could be effective in preventing NIDs/RIDs in communal accommodations. Screening, prompt therapy, and infection protection measures are necessary to prevent the transmission of diseases.
PURPOSE: In 2016, the number of refugees worldwide reached 65.6 million. So far, only limited data are available on the health status of refugees and asylum seekers (RAs). Especially, notifiable infectious diseases (NIDs) carry the risk of outbreaks in communal accommodations hosting RAs. METHODS: We conducted a monocentric retrolective cross-sectional study including 15,137 RAs treated in a special health care unit for RAs located in the major reception center in Munich from November 2014 to October 2016. Altogether 811 RAs with NIDs according to sections 6 and 7 of the German Infection Protection Act or with other infections relevant in the setting of a communal accommodation (RIDs) could be identified. RESULTS: The gender and age distribution was generally comparable to that of refugees in Germany. However, patients from East Africa and Nigeria were significantly overrepresented. NIDs/RIDs were dominated by cases of tuberculosis, hepatitis B, and vaccine-preventable and parasitic diseases. Significant risk factors included country of origin (COI) and age for hepatitis B, age for hepatitis C, gender and age for HIV, and COI, gender and age for tuberculosis and ectoparasitosis. Calculated prevalences of hepatitis B, hepatitis C, and HIV were mostly below those of the COI. Incidences of tuberculosis were mostly strongly elevated. CONCLUSIONS:COI, gender, and age have an impact on the occurrence of NIDs/RIDs. Early vaccinations and improved hygiene could be effective in preventing NIDs/RIDs in communal accommodations. Screening, prompt therapy, and infection protection measures are necessary to prevent the transmission of diseases.
Authors: Constantine Bloch-Infanger; Veronika Bättig; Jürg Kremo; Andreas F Widmer; Adrian Egli; Roland Bingisser; Manuel Battegay; Stefan Erb Journal: PLoS One Date: 2017-06-15 Impact factor: 3.240
Authors: Sofanne J Ravensbergen; Mariëtte Lokate; Darren Cornish; Eveline Kloeze; Alewijn Ott; Alex W Friedrich; Rob van Hest; Onno W Akkerman; Wiel C de Lange; Tjip S van der Werf; Erik Bathoorn; Ymkje Stienstra Journal: PLoS One Date: 2016-05-04 Impact factor: 3.240
Authors: Mishal S Khan; Anna Osei-Kofi; Abbas Omar; Hilary Kirkbride; Anthony Kessel; Aula Abbara; David Heymann; Alimuddin Zumla; Osman Dar Journal: Lancet Infect Dis Date: 2016-06-20 Impact factor: 25.071
Authors: Natalia Skogberg; Päivikki Koponen; Paula Tiittala; Katri-Leena Mustonen; Eero Lilja; Olli Snellman; Anu Castaneda Journal: BMJ Open Date: 2019-04-08 Impact factor: 2.692
Authors: Christian Dopfer; Annabelle Vakilzadeh; Christine Happle; Evelyn Kleinert; Frank Müller; Diana Ernst; Reinhold E Schmidt; Georg M N Behrens; Sonja Merkesdal; Martin Wetzke; Alexandra Jablonka Journal: Int J Environ Res Public Health Date: 2018-09-05 Impact factor: 3.390
Authors: Paula Tiittala; Karolina Tuomisto; Taneli Puumalainen; Outi Lyytikäinen; Jukka Ollgren; Olli Snellman; Otto Helve Journal: BMC Public Health Date: 2018-09-24 Impact factor: 3.295
Authors: Ales Janda; Kristin Eder; Roland Fressle; Anne Geweniger; Natalie Diffloth; Maximilian Heeg; Nadine Binder; Ana-Gabriela Sitaru; Jan Rohr; Philipp Henneke; Markus Hufnagel; Roland Elling Journal: PLoS Med Date: 2020-03-31 Impact factor: 11.069
Authors: Ingmar Schäfer; Jan Hendrik Oltrogge; Susanne Pruskil; Claudia Mews; Dana Schlichting; Martin Jahnke; Hans-Otto Wagner; Dagmar Lühmann; Martin Scherer Journal: BMJ Open Date: 2020-10-22 Impact factor: 2.692